Cardiff Oncology Inc
NASDAQ:CRDF
Cardiff Oncology Inc
NASDAQ:CRDF
Price:
1.67
USD
-3.47%
Market Closed
Market Cap:
$114.2m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Cardiff Oncology Inc
NASDAQ:CRDF
|
US |
Wall St Price Targets
CRDF Price Targets Summary
Cardiff Oncology Inc
Cardiff Oncology Inc
Wall Street analysts forecast CRDF stock price to rise over the next 12 months.
According to Wall Street analysts, the average 1-year price target for CRDF is 8.74 USD with a low forecast of 3.54 USD and a high forecast of 12.6 USD.
Lowest Forecast
Price Target
3.54
USD
112% Upside
Average Forecast
Price Target
8.74
USD
424% Upside
Highest Forecast
Price Target
12.6
USD
654% Upside
Why do you have more estimates than other sites?
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is CRDF's stock price target?
Price Target
8.74
USD
8.74
USD
According to Wall Street analysts, the average 1-year price target for CRDF is 8.74 USD with a low forecast of 3.54 USD and a high forecast of 12.6 USD.
What is the Revenue forecast for Cardiff Oncology Inc?
Projected CAGR
166%
166%
Over the last 14 years, the compound annual growth rate for Revenue has been 6%. The projected CAGR for the next 8 years is 166%.
